207_Combined course Presentations
RAPIDO Trial
N = 885 patients
SCPRT 5X5 GY
CapOx + 6
R A N D O M I Z A T I O N
T M E
T4 EMVI + N2 CRM +
Capecitabine: 825 mg/m2 Oxaliplatin: 130 mg/m2
Standard CRT
Primary endpoint 3 year DFS
Made with FlippingBook
RAPIDO Trial
N = 885 patients
SCPRT 5X5 GY
CapOx + 6
R A N D O M I Z A T I O N
T M E
T4 EMVI + N2 CRM +
Capecitabine: 825 mg/m2 Oxaliplatin: 130 mg/m2
Standard CRT
Primary endpoint 3 year DFS
Made with FlippingBook